TABLE 1.

Baseline characteristics of patients

CharacteristicValue for treatment armValue for total (n = 170)
d4T-3TC-IDV (n = 85)AZT-3TC-IDV (n = 85)
Sex, no. (%) male68 (80)67 (79)135 (79)
Age, yr
    Median363737
    25%-75%32-4233-4733-44
Prior nRTI
    Median duration     (mo)19.618.919.5
    25%-75%12-37.313-38.312-37.9
    No. (%) of patients     exposed to:
        AZT-ddI49 (58)40 (47)89 (52)
        AZT-ddC29 (34)35 (41)64 (38)
        AZT-ddC and         AZT-ddI5 (6)8 (9)13 (8)
CDCa status, no. (%)
    CDC-A41 (48)39 (46)80 (47)
    CDC-B33 (39)39 (46)72 (42)
    CDC-C11 (13)7 (8)18 (11)
CD4 cells/mm3
    Median291292291
    25%-75%216-370225-368221-368
HIV RNA level, log10     copies/ml
    Median4.424.334.36
    25%-75%4.07-4.684.1-4.644.08-4.66
  • a CDC, Centers for Disease Control and Prevention.